These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3287706)

  • 1. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of leptin in heart, liver and kidney transplant recipients.
    Kagan A; Haran N; Leschinsky L; Sarafian R; Aravot D; Dolberg J; Ben-Ary Z; Rapoport J
    Isr Med Assoc J; 2002 Mar; 4(3):213-7. PubMed ID: 11908268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of cyclosporin A in whole blood and plasma in five patients with different hematocrits.
    Agarwal RP; McPherson RA; Threatte GA
    Ther Drug Monit; 1985; 7(1):61-5. PubMed ID: 3887670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New specific cyclosporine (CY) assay prompts different CY dosages in renal transplant recipients.
    Weinbeck M; Keller E; Kirste G; Wilms H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1475. PubMed ID: 2652472
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal response to volume expansion in heart-transplant and kidney-transplant recipients.
    Pruszczynski W; Drieu L; Cabrol C; Rondeau E; Ardaillou R
    Clin Nephrol; 1987 Aug; 28(2):65-72. PubMed ID: 3308232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A-induced side effects in renal transplantation are related to the ratio of nonspecific/specific cyclosporin blood trough levels as analysed by radioimmunoassay.
    Harfmann P; Dittmer R; Busch R; Tenschert W; Arndt R
    Transplant Proc; 1990 Oct; 22(5):2369-72. PubMed ID: 2219404
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measuring cyclosporin in immunosuppressive treatment following liver and heart transplantation].
    Hamilton G; Roth E; Mühlbacher F; Funovics J; Piza F; Schindler J; Woloszcuk W; Havel M; Laczkovics A
    Wien Klin Wochenschr; 1986 Dec; 98(24):820-4. PubMed ID: 3548080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose response kinetics of cyclosporine.
    Bozkurt F; Stierle H; Schollmeyer P; Keller E
    Clin Nephrol; 1987 Jul; 28(1):10-4. PubMed ID: 3304744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine blood concentrations in the management of renal transplant recipients.
    Rogerson ME; Marsden JT; Reid KE; Bewick M; Holt DW
    Transplantation; 1986 Feb; 41(2):276-8. PubMed ID: 3511588
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative determination of cyclosporin A in whole blood and plasma by high performance liquid chromatography.
    Shibata N; Minouchi T; Hayashi Y; Ono T; Shimakawa H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):261-71. PubMed ID: 3310157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
    Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
    J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine monitoring in kidney and liver transplant patients: comparison between radioimmunoassay (37 degrees C plasma) and high-performance liquid chromatography (whole blood) measurements.
    Mojaverian P; Green PJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):414-8. PubMed ID: 3284085
    [No Abstract]   [Full Text] [Related]  

  • 14. A model to account for the variation in cyclosporin binding to plasma lipids in transplant patients.
    Legg B; Gupta SK; Rowland M
    Ther Drug Monit; 1988; 10(1):20-7. PubMed ID: 3287705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hematocrit on cyclosporine (cyclosporin A) in whole blood and plasma of renal-transplant patients.
    Rosano TG
    Clin Chem; 1985 Mar; 31(3):410-2. PubMed ID: 3882273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of pharmacokinetic profiles in 232 renal and 87 cardiac allograft recipients treated with cyclosporine.
    Kahan BD; Kramer WG; Wideman CA; Frazier OH; Lorber MI; Williams C; Flechner SM; Cooley DA; Van Buren CT
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):115-9. PubMed ID: 3538563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-to-plasma distribution of cyclosporin A in a renal transplant recipient.
    Shibata N; Minouchi T; Hayashi Y; Shibata H; Ono T; Shimakawa H
    Eur J Clin Pharmacol; 1988; 35(4):443-4. PubMed ID: 3058487
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin: erythrocyte binding and an examination of its use to estimate unbound concentration.
    Legg B; Rowland M
    Ther Drug Monit; 1988; 10(1):16-9. PubMed ID: 3376178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.